DRUG

SGLT2i

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for SGLT2i

Glioblastoma 1

Mediator Outcome Score Tier Lit. status Trial
mTOR glioblastoma 0.208 Mid partial evidence none

Clinical trials

200 registered trials for SGLT2i

Source: ClinicalTrials.gov

← All drugs